XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech operating margin
Operating margin is operating income as a percentage of revenue.
XBiotech's operating margin for the twelve months ending Sep 30, 2023 was -12361.7%. For fiscal 2022 it was -860.1%, against -136.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -860.1% | −723.7 |
| FY2021 | Dec 31, 2021 | -136.4% | −94.8 |
| FY2020 | Dec 31, 2020 | -41.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -2720.7% | −2560.8 |
| Q3 FY2022 | Sep 30, 2022 | -380.3% | −297.7 |
| Q2 FY2022 | Jun 30, 2022 | -790.5% | −556.1 |
| Q1 FY2022 | Mar 31, 2022 | -1569.0% | −1495.7 |
| Q4 FY2021 | Dec 31, 2021 | -159.8% | −66.4 |
| Q3 FY2021 | Sep 30, 2021 | -82.6% | −38.3 |
| Q2 FY2021 | Jun 30, 2021 | -234.4% | −192.3 |
| Q1 FY2021 | Mar 31, 2021 | -73.3% | −56.1 |
| Q4 FY2020 | Dec 31, 2020 | -93.4% | – |
| Q3 FY2020 | Sep 30, 2020 | -44.3% | – |
| Q2 FY2020 | Jun 30, 2020 | -42.0% | – |
| Q1 FY2020 | Mar 31, 2020 | -17.1% | – |
See a number that looks wrong?